Skip to content
drillr.ai
Sign up

ABUS

Arbutus Biopharma Corporation

NASDAQ · Healthcare · Biotechnology · US

$5.15
+0.59%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+20.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 10, 2026Sawhney Roger · directorA-Award78,800$4.24
Jun 10, 2026Beardsley Robert A · directorA-Award78,800$4.24
Feb 2, 2026Nguyen Tuan · officer: Chief Financial OfficerA-Award73,500$0.00
Feb 2, 2026Androski Lindsay · director, officer: President and CEOA-Award28,000$0.00
Feb 2, 2026Androski Lindsay · director, officer: President and CEOA-Award71,700$4.39
Feb 2, 2026Nguyen Tuan · officer: Chief Financial OfficerA-Award188,400$4.39
Aug 6, 2025Sawhney Roger · directorA-Award157,600$3.34
Apr 1, 2025Nguyen Tuan · officer: Chief Financial OfficerA-Award750,000$3.49
Mar 31, 2025Nguyen Tuan · officer: Chief Financial OfficerA-Award750,000$3.50
Mar 20, 2025Androski Lindsay · director, officer: President and CEOA-Award310,422$3.20
Mar 20, 2025Beardsley Robert A · directorA-Award157,600$3.20
Mar 20, 2025Hasija Anuj · directorA-Award157,600$3.20
Feb 19, 2025McElhaugh Michael J. · director, officer: Interim President & CEOA-Award177,000$0.00
Feb 19, 2025McElhaugh Michael J. · director, officer: Interim President & CEOA-Award718,800$3.29
Feb 19, 2025HASTINGS DAVID C · officer: Chief Financial OfficerA-Award365,800$3.29
Feb 19, 2025HASTINGS DAVID C · officer: Chief Financial OfficerA-Award90,100$0.00
Feb 19, 2025Sims Karen · officer: Chief Medical OfficerA-Award200,300$3.29
Feb 19, 2025Sims Karen · officer: Chief Medical OfficerA-Award49,300$0.00
Feb 19, 2025Naftzger J. Christopher · officer: General Counsel and CCOA-Award220,300$3.29
Feb 19, 2025Naftzger J. Christopher · officer: General Counsel and CCOA-Award54,300$0.00
Feb 5, 2025McElhaugh Michael J. · director, officer: Interim President & CEOSale23,790$3.28
Feb 5, 2025Naftzger J. Christopher · officer: General Counsel and CCOSale11,333$3.28
Feb 5, 2025HASTINGS DAVID C · officer: Chief Financial OfficerSale22,183$3.28
Feb 5, 2025Sims Karen · officer: Chief Medical OfficerSale19,348$3.28
Aug 16, 2024MANCHESTER KEITH S · directorM-Exempt54,915$0.56
Aug 16, 2024MANCHESTER KEITH S · directorSale8,846$3.69
May 24, 2024BURGESS DANIEL D · directorA-Award67,000$3.28
May 24, 2024MANCHESTER KEITH S · directorA-Award67,000$3.28
May 24, 2024HENRIQUES RICHARD C JR · directorA-Award67,000$3.28
May 24, 2024Meyers James R · directorA-Award67,000$3.28
Institutional positioning

13F filings over the trailing two quarters

New 64Increased 109Reduced 95Sold out 24
FilerActionSharesFiled
MORGAN STANLEYReduced25,891,480May 15, 2026
Two Seas Capital LPIncreased19,095,583Aug 12, 2026
TWO SEAS CAPITAL LPIncreased18,557,543May 15, 2026
MORGAN STANLEYReduced17,698,305Aug 13, 2026
Whitefort Capital Management, LPIncreased15,794,261Aug 14, 2026
WHITEFORT CAPITAL MANAGEMENT, LPIncreased14,930,885May 15, 2026
BlackRock, Inc.Increased13,766,071Aug 7, 2026
BLACKROCK, INC.Reduced12,966,946May 13, 2026
STATE STREET CORPIncreased7,869,179Aug 7, 2026
Rubric Capital Management LPIncreased7,532,937Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased7,010,679Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position6,688,911May 15, 2026
RUBRIC CAPITAL MANAGEMENT LPIncreased6,626,389May 15, 2026
STATE STREET CORPIncreased6,342,510May 15, 2026
BARCLAYS PLCIncreased4,316,095May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 10, 2026